EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
02 déc. 2022 08h00 HE
|
Novan, Inc.
– Agreement provides immediate access to cash flow – – EPI Health leveraging accounts receivables from commercial product sales to bolster working capital needs – DURHAM, N.C., Dec. 02, 2022 ...
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
01 déc. 2022 09h00 HE
|
Novan, Inc.
– Paula Brown Stafford, President and Chief Executive Officer of Novan to participate in a live moderated panel discussion on Thursday, December 8th at 11:00 AM ET – DURHAM, N.C., Dec. 01, 2022 ...
EdgarAgents Names Stephen J. Bonventre as Chief Executive Officer
29 nov. 2022 07h00 HE
|
Edgar Agents
NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) -- EdgarAgents LLC, one of the fastest growing financial technology service providers in the United States, has announced that its Board has appointed...
Balincan USA Inc. (BCNN) Letter to our Shareholders
18 nov. 2022 00h00 HE
|
Balincan USA, Inc.
COLORADO SPRINGS, Colo., Nov. 18, 2022 (GLOBE NEWSWIRE) -- This is the BCNN Board of Directors letter to shareholders. To our Shareholders This is the first letter to our shareholders, and we are...
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
14 nov. 2022 07h00 HE
|
Novan, Inc.
– Rhofade prescriptions increased 37% for third quarter year-to-date from prior year – – Continued progress toward submission of berdazimer gel, 10.3% (SB206) New Drug Application (NDA), targeted...
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
07 nov. 2022 09h00 HE
|
Novan, Inc.
DURHAM, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its third quarter 2022 financial results on Monday,...
EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
21 oct. 2022 08h35 HE
|
Novan, Inc.
DURHAM, N.C. and COPENHAGEN, Denmark, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), EPI Health, a Novan Company, and MC2 Therapeutics today announced...
EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference®
21 oct. 2022 08h35 HE
|
Novan, Inc.
DURHAM, N.C. and COPENHAGEN, Denmark, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), EPI Health, a Novan Company, and MC2 Therapeutics today announced that...
Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®
14 oct. 2022 08h30 HE
|
Novan, Inc.
DURHAM, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN) and EPI Health, a Novan Company, today announced that eight abstracts have been accepted for...
How Newswire's Media Advantage Platform Transforms Press Release Distribution into Real Results for CEOs
19 sept. 2022 09h31 HE
|
Newswire
SARASOTA, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- In public relations, sometimes even the most newsworthy announcements can fall flat. There are many best practices to follow, according to various...